New Research Moves Us One Step Closer To Personalised Breast Cancer Treatment

News — By on December 17, 2008 at 5:00 am

CANCER RESEARCH UK scientists have found that a test, already used in breast cancer diagnosis, can also predict who will and who won’t benefit from commonly used chemotherapy drugs. The research shows that women who have a duplication of chromosome 17 in their tumour will benefit from anthracycline drugs, while others can be spared the side-effects of the treatment.

Please read the complete article and let us know what you think below.

Leave a Reply

Trackbacks

Leave a Trackback